Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 80255 BALTIMORE, MD
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$265,988
+$205,353 QoQ
Shares Held
27,225
+150.1% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 96 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. KPTI ranks #233 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in KPTI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $265,988 27,225
2026-03-31 $60,635 10,886
2025-12-31 $80,120 10,886
2025-09-30 $71,194 10,886
2025-06-30 $46,918 10,886
2024-12-31 $43,466 64,300
2024-09-30 $111,801 134,700
2024-06-30 $84,282 97,100
2024-03-31 $143,587 95,091
2023-12-31 $75,352 87,113
2023-09-30 $116,731 87,113
2023-06-30 $121,913 68,108
2023-03-31 $235,212 60,466
2022-12-31 $197,047 57,955
2022-09-30 $286,824 52,532
2022-06-30 $169,891 37,670
2022-03-31 $193,816 26,298
2021-12-31 $131,249 20,412
2021-09-30 $261,387 44,912
2021-06-30 $4,118,701 399,099
2021-03-31 $5,185,886 492,955
2020-12-31 $22,552,827 1,456,901
2020-09-30 $20,980,360 1,437,011
2020-06-30 $37,152,325 1,961,580
2020-03-31 $26,792,936 1,394,739